US Stock MarketDetailed Quotes

BPMC Blueprint Medicines

Watchlist
  • 93.940
  • -1.250-1.31%
Close Feb 14 16:00 ET
  • 93.940
  • 0.0000.00%
Post 17:01 ET
6.00BMarket Cap-87.79P/E (TTM)

Blueprint Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Blueprint Medicines Q4 2024 Earnings Date

Currency：USDFeb 13, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
145.18M
146.37M
+1.18M
Beat Est.
+101.76%
+103.41%
+0.82%
EPS
-0.71
-0.79
-0.08
Miss Est.
+61.02%
+56.59%
-11.36%
Analyst Rating
Strong Buy

Feb 17, 2025

Blueprint Medicines Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 17 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 176.323M--
--2025/Q1-- / 160.292M--
Feb 13, 20252024/Q4146.366M / 145.182M--
Oct 30, 20242024/Q3128.184M / 127.466M--
Aug 1, 20242024/Q2138.157M / 103.938M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 176.323M--
--2025/Q1-- / 160.292M--
Feb 13, 20252024/Q4146.366M / 145.182M--
Oct 30, 20242024/Q3128.184M / 127.466M--
Aug 1, 20242024/Q2138.157M / 103.938M--

Unlock Free Earnings Estimates

Blueprint Medicines Earnings Reports

  • Blueprint Medicines | 10-K: FY2024 Annual Report

    Feb 13 17:15 ET

  • Blueprint Medicines | 8-K: Blueprint Medicines Reports Fourth Quarter and Full Year 2024 Results

    Feb 13 07:39 ET

  • Blueprint Medicines | 10-Q: Q3 2024 Earnings Report

    Oct 30, 2024 16:32 ET

  • Blueprint Medicines | 8-K: Blueprint Medicines Reports Third Quarter 2024 Results and Raises AYVAKIT® / AYVAKYT ® (avapritinib) Full Year Revenue Guidance

    Oct 30, 2024 07:11 ET

    • Read more

    Trending Stocks
    U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

    Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

    Symbol Mini Chart % Chg
    Argo Blockchain
    ARBK
    +5.33%
    BTCS Inc
    BTCS
    +3.20%
    Canaan
    CAN
    +2.29%
    Bit Origin
    BTOG
    +1.90%
    Bitfarms
    BITF
    +1.43%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 17, 2025

    Strong Buy

    • Buy

      78.57%

    • Hold

      21.43%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Cancer Research
    Cancer Research
    Intraday-1.84%